Head-to-head · Value Score
CoreAge Rx vs Lttl
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Lttl a 78. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLttl
#56 · Grade B- · Fair Price
Est. first month
$109/mo
Save ~92% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 78 — an est. $99/mo first month, with no teaser step-up baked in. Lttl isn't out of it: Savings-focused shoppers who want a published, no-step-up price and like the option to start on a cheaper, lower-dose Microdose plan before committing to the standard dose.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Lttl |
|---|---|---|
| Value Score | 93 (A+) | 78 (B-) |
| Est. first month | $99/mo | $109/mo |
| Save vs brand-name | ~89% | ~92% |
| Semaglutide | $99/mo | $129/mo standard — Microdose Semaglutide from $109/mo (lower dose, fewer side effects) — same price at every dose, no contracts |
| Tirzepatide | $149/mo | $199/mo standard — Microdose Tirzepatide from $109/mo — same price at every dose, no contracts |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Lttl
Same-price-every-dose compounded semaglutide ($129/mo) and tirzepatide ($199/mo), plus a genuinely lower-dose Microdose tier at $109/mo for anyone starting cautious.
Why it's a deal
- "Same price at every dose" — a real anti-teaser structure, not just a starting rate, with no contract and cancel-anytime
- A genuine Microdose tier (Microdose Semaglutide / Microdose Tirzepatide, both from $109/mo) for people who want a lower dose and fewer side effects, not just a lower price
- Free 2-minute assessment reviewed by a named, credentialed Medical Advisory Board (a pharmacist, a nurse practitioner, and a physical therapist), not an algorithm
- FDA-registered pharmacy partners, FSA/HSA eligible, free shipping
The fine print
- No FDA-approved brand-name GLP-1 option — compounded only
- No oral/sublingual GLP-1 route — injection only for both the standard and Microdose lines
- Pharmacy partners are named as a category ("FDA-Registered Pharmacy Partners") rather than by individual name
- States served are not publicly listed — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Lttl.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.